SCYX | SCYNEXIS, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.9006 - 1.0150
52 Week Range	0.9006 - 3.07
Beta	1.86
Implied Volatility	72.37%
IV Rank	100.00%
Day's Volume	398,169
Average Volume	160,715
Shares Outstanding	37,949,000
Market Cap	37,945,205
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2014-05-02

Valuation
Profitability
Growth
Health
P/E Ratio	-1.32
Forward P/E Ratio	N/A
EPS	-0.76
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	29
Country	USA
Website	SCYX

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

SCYX's peers: BFRI, GHSI, SHPH, AKAN, CPHI, EGRX, PAHC, SSIC, PCRX, TKNO, LFCR, KMDA, CPIX, IRWD, MNK, ORGO, LSDI, ALIM, ANIP

*Chart delayed

Analyzing fundamentals for SCYX we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see SCYX Fundamentals page.

Watching at SCYX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SCYX Technicals page.